Neuropsychiatric reaction induced by abacavir in a pediatric human immunodeficiency virus-infected patient.
Pere
P
Soler Palacin
Angela
A
Aramburo
Fernando A
FA
Moraga
Maria Josep
MJ
Cabañas
Concepció
C
Figueras
D019380:Anti-HIV Agents / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced; D002648:Child; D003863:Depression / Q000139:chemically induced; D015224:Dideoxynucleosides / Q000009:adverse effects*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D012893:Sleep Wake Disorders / Q000139:chemically induced; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir